HomeLTRN • NASDAQ
add
Lantern Pharma Inc
Previous close
$3.21
Day range
$3.13 - $3.58
Year range
$2.56 - $7.21
Market cap
38.07M USD
Avg Volume
37.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
14 hours ago
S&P 500 tallies its first ‘death cross’ in 3 years. Here’s what happens next.
0.79%
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.90M | 20.89% |
Net income | -5.88M | -40.36% |
Net profit margin | — | — |
Earnings per share | -0.54 | -42.11% |
EBITDA | -5.89M | -20.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.01M | -41.86% |
Total assets | 25.57M | -41.41% |
Total liabilities | 4.38M | 60.02% |
Total equity | 21.19M | — |
Shares outstanding | 10.78M | — |
Price to book | 1.64 | — |
Return on assets | -52.77% | — |
Return on capital | -61.01% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -5.88M | -40.36% |
Cash from operations | -3.97M | -17.32% |
Cash from investing | 3.45M | 1,245.63% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -591.74K | 83.72% |
Free cash flow | -1.98M | -6.77% |
About
Founded
2013
Headquarters
Website
Employees
24
